The store will not work correctly when cookies are disabled.
n-Propyl 2,3-dideoxy-alpha-D-glycero-hex-2-enopyranosid-4-ulose
ID: ALA4062739
PubChem CID: 137634826
Max Phase: Preclinical
Molecular Formula: C9H14O4
Molecular Weight: 186.21
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCO[C@@H]1C=CC(=O)[C@@H](CO)O1
Standard InChI: InChI=1S/C9H14O4/c1-2-5-12-9-4-3-7(11)8(6-10)13-9/h3-4,8-10H,2,5-6H2,1H3/t8-,9+/m1/s1
Standard InChI Key: DFMPUUREPFEAEY-BDAKNGLRSA-N
Molfile:
RDKit 2D
13 13 0 0 0 0 0 0 0 0999 V2000
3.2001 -10.5752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2001 -11.4003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9121 -11.8087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6242 -11.4003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6242 -10.5752 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9121 -10.1586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9121 -9.3336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6266 -8.9211 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3381 -11.8138 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3368 -12.6388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0507 -13.0524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4844 -10.1649 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0495 -13.8774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 1
7 8 1 0
4 9 1 6
9 10 1 0
10 11 1 0
1 12 2 0
11 13 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 186.21 | Molecular Weight (Monoisotopic): 186.0892 | AlogP: 0.26 | #Rotatable Bonds: 4 |
Polar Surface Area: 55.76 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 0.99 | CX LogD: 0.99 |
Aromatic Rings: ┄ | Heavy Atoms: 13 | QED Weighted: 0.68 | Np Likeness Score: 1.29 |
References
1. Santos JAM, Santos CS, Almeida CLA, Silva TDS, Freitas Filho JR, Militão GCG, da Silva TG, da Cruz CHB, Freitas JCR, Menezes PH.. (2017) Structure-based design, synthesis and antitumoral evaluation of enulosides., 128 [PMID:28189083] [10.1016/j.ejmech.2017.01.036] |